Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -4.40% and Operating profit at -206.69% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 0.07% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -4.40% and Operating profit at -206.69% over the last 5 years
3
Flat results in Jun 26
4
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,504 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.23
-7.24%
2.79
Revenue and Profits:
Net Sales:
151 Million
(Quarterly Results - Jun 2026)
Net Profit:
-25 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.75%
0%
5.75%
6 Months
-16.14%
0%
-16.14%
1 Year
18.32%
0%
18.32%
2 Years
95.9%
0%
95.9%
3 Years
23.2%
0%
23.2%
4 Years
33.52%
0%
33.52%
5 Years
31.32%
0%
31.32%
Zhong Zhu Healthcare Holding Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.40%
EBIT Growth (5y)
-206.69%
EBIT to Interest (avg)
-78.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.30
Tax Ratio
6.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.07%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.64
EV to EBIT
-27.37
EV to EBITDA
-41.57
EV to Capital Employed
3.12
EV to Sales
7.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.39%
ROE (Latest)
-7.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
150.50
108.80
38.33%
Operating Profit (PBDIT) excl Other Income
-12.80
-10.10
-26.73%
Interest
0.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-24.50
-22.00
-11.36%
Operating Profit Margin (Excl OI)
-174.10%
-216.00%
4.19%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 38.33% vs -24.55% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -11.36% vs 73.24% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
575.50
519.70
10.74%
Operating Profit (PBDIT) excl Other Income
-66.40
-207.70
68.03%
Interest
1.20
1.10
9.09%
Exceptional Items
-7.00
-175.30
96.01%
Consolidate Net Profit
-112.90
-625.20
81.94%
Operating Profit Margin (Excl OI)
-227.70%
-535.20%
30.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.74% vs -18.32% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 81.94% vs -84.75% in Dec 2024
About Zhong Zhu Healthcare Holding Co., Ltd. 
Zhong Zhu Healthcare Holding Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






